Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group

Hematopoietic stem cell transplantation (HSCT) is a curative post-remission treatment in patients with acute myeloid leukemia (AML), but relapse after transplant is still a challenging event. In recent year, several studies have investigated the molecular minimal residual disease (qPCR-MRD) as a pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Benetton, Maddalena, Merli, Pietro, Walter, Christiane, Hansen, Maria, Da Ros, Ambra, Polato, Katia, Tregnago, Claudia, Abrahamsson, Jonas, Strocchio, Luisa, Sonneveld, Edwin, Fogelstrand, Linda, Von Neuhoff, Nils, Reinhardt, Dirk, Hasle, Henrik, Pigazzi, Martina, Locatelli, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313005/
https://www.ncbi.nlm.nih.gov/pubmed/35884834
http://dx.doi.org/10.3390/biomedicines10071530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313005/
https://www.ncbi.nlm.nih.gov/pubmed/35884834
http://dx.doi.org/10.3390/biomedicines10071530

Ejemplares similares